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ABSTRACT
Objective To evaluate a cognitive test, the TYM (“test your
memory”), in the detection of Alzheimer’s disease.
Design Cross sectional study.
Setting Outpatient departments in three hospitals,
including a memory clinic.
Participants540controlparticipantsaged18-95and139
patients attending a memory clinic with dementia/
amnestic mild cognitive impairment.
Intervention Cognitive test designed to use minimal
operator time and to be suitable for non-specialist use.
Main outcome measures Performance of normal controls
on the TYM. Performance of patients with Alzheimer’s
disease on the TYM compared with age matched controls.
Validation of the TYM with two standard tests (the mini-
mental state examination (MMSE) and the Addenbrooke’s
cognitive examination-revised (ACE-R)). Sensitivity and
specificity of the TYM in the detection of Alzheimer’s
disease.
Results Control participants completed the TYM with an
average score of 47/50. Patients with Alzheimer’sd i s e a s e
scored anaverageof 33/50. The TYM score showsexcellent
correlation with the two standard tests. A score of ≤42/50
had a sensitivity of 93% and specificity of 86% in the
diagnosis of Alzheimer’sd i s e a s e .T h eT Y Mw a sm o r e
sensitive in detection of Alzheimer’s disease than the mini-
mental examination, detecting 93% of patients compared
with 52% for the mini-mental state exxamination. The
negative and positive predictive values of the TYM with the
cut off of ≤42 were 99% and 42% with a prevalence of
Alzheimer’s disease of 10%. Thirty one patients with non-
Alzheimer dementias scored an average of 39/50.
Conclusions The TYM can be completed quickly and
accurately by normal controls. It is a powerful and valid
screening test for the detection of Alzheimer’s disease.
INTRODUCTION
Dementia and other cognitive problems are common.
An estimated 24 million individuals in the world have
dementia and the number affected will double every
20 years.
1 Milder forms of cognitive dysfunction,
including mild cognitive impairment, affect many
more people.
2 Alzheimer’s disease is the commonest
form of dementia. Cognitive problems are a feature of
many neurological and medical diseases including
stroke, Parkinson’s disease, head injury, and epilepsy.
Assessmentofapatient’scognitionisacrucialpartof
many medical consultations. Cognitive tests aid the
diagnosisofdementiaandareimportantinthemedical
and social management of patients and in the assess-
ment of capacity. Once there are effective treatments
for Alzheimer’s disease there will be an even greater
need for a quick sensitive test that is suitable for use in
primary care and by non-specialists.
Many cognitive tests are available but none meets
the three critical requirements for widespread use by
anon-specialist—thatis,takeminimaloperatortimeto
administer, test a reasonable range of cognitive func-
tions, and are sensitive to mild Alzheimer’s disease.
We designed the TYM (“test your memory”) to fulfil
these requirements. The paradox of thorough testing
in minimal time was achieved by allowing patients to
fill in the test themselves.
The TYM was administered to 540 normal controls
aged 18-95, 108 patients with Alzheimer’s disease/
amnestic mild cognitive impairment, and 31 patients
with non-Alzheimer’s degenerative dementias. The
test was validated by comparing scores with those
obtained with the mini-mental state examination
3 and
Addenbrooke’s cognitive examination-revised.
4 The
Addenbrooke’s revised test was developed from the
original examination
5 and is similar in both content
and scoring.
4 We determined the specificity and sensi-
tivity of the TYM in the detection of Alzheimer’s dis-
ease by comparing the scores of 94 patients with
Alzheimer’sdiseasewiththescoresof282agematched
controls. Three scorers of differing backgrounds
marked 100 tests to assess inter-rater reliability.
METHODS
The TYM test
TheTYMisaseriesof10tasksonadoublesidedsheet
of card with spaces for the patient to fill in (see appen-
dix 1 on bmj.com). The patient’s ability to complete
the test is an 11th task. The tasks are orientation (10
points), ability to copy a sentence (2 points), semantic
knowledge(3 points),calculation (4 points),verbal flu-
ency (4 points), similarities (4 points), naming (5
points), visuospatial abilities ( 2 tasks, total 7 points),
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do the test is also scored (5 points), giving a possible
totalof50points.Thescoresforthesubsetsareprinted
onthecardandthetotalscorecalculatedbyaddingthe
subset scores. To ensure consistent scoring a single
sheet of scoring instructions is available.
Participants
Selection of patients with Alzheimer’s disease
Patientswereseenanddiagnosedbyaconsultantneurol-
ogist withaninterestindementiainadedicatedmemory
clinic at Addenbrooke’s Hospital. Patients attended the
memory clinic between March and December 2007 and
underwent neurological assessment, the Addenbrooke’s
cognitive examination-revised (which includes the mini-
mentalstateexamination),structuralimaging,andblood
tests. Many also had a psychiatric and neuropsychologi-
calassessment.ThediagnosisofAlzheimer’sdiseasewas
made with the NINCDS-ARDRA (National Institute of
NeurologicalandCommunicativeDisordersandStroke-
Alzheimer’sDiseaseandRelatedDisordersAssociation)
criteria for probable Alzheimer’s
6 without reference to
theTYMresult.Thediagnosisofamnesticmildcognitive
impairment was made according to published criteria.
7
We excluded patients whose cognitive problems were
thought to be substantially caused by depression.
A totalof 108 patients(59 men,49 women) received
a clinical diagnosis of Alzheimer’s disease or amnestic
mild cognitive impairment. Alzheimer’s disease was
diagnosed in 85 and amnestic mild cognitive impair-
ment in 23. Amnestic mild cognitive impairment has
clinical and pathological similarities to Alzheimer’s
disease
89 and patients with amnestic mild cognitive
impairment who score poorly on the Addenbrooke’s
cognitive examination are likely to progress to Alzhei-
mer’s disease.
10 These patients were regarded as hav-
ing early Alzheimer’s disease. Nine patients with a
diagnosis of amnestic mild cognitive impairment who
scored below the cut off for dementia on the Adden-
brooke’s cognitive examination-revised (≤83
4) were
included in the Alzheimer’s cohort. Patients with a
diagnosis of amnestic mild cognitive impairment who
score well on the Addenbrooke’s cognitive examina-
tion are unlikely to progress to Alzheimer’s disease
over the next two years
10; such patients might never
progress to Alzheimer’s disease and might return to
normal.
11 The 14 patients with a diagnosis of amnestic
mild cognitive impairment who scored >83 on the
ACE-R were analysed separately.
Selection of controls
Controls were recruited from relatives accompanying
patients to the memory clinic. Additional controls
wererecruitedfromrelativesofpatientsattendingneu-
rology and medical outpatients departments at two
other hospitals. We also included some dermatology
outpatients.Weexcludedpeoplewithahistoryofneu-
rological disease, memory problems, or brain injury.
All participants gave informed consent.
We tested 540 controls aged 18-95. Over half (54%)
were women. We calculated normal values for each
decade from the age of 30 with standard errors. Three
age matched controls were selected for each patient
with Alzheimer’s disease. To assess any differences in
controlsbetweendifferenthospitals,wecompared100
controls from Addenbrooke’s with 100 age matched
controls from the other hospitals. To assess any sex
differences, we compared 100 male controls with 100
age matched female controls.
Testing and validation
The 94 patients in the Alzheimer’s cohort were given
the TYM as well as the Addenbrooke’s cognitive
examination-revised (that includes the mini-mental
state examination). The TYM was administered when
the patient first arrived in the clinic.
We compared the scores of patients and age matched
controlsonsubsetsandtotalscoresusingttestswithBon-
ferroni correction for multiple comparisons (equal var-
iances not assumed). We compared the TYM scores of
patientswiththeAddenbrooke’sandmini-mentalscores
using Pearson’s correlation coefficients. The internal
consistencyoftheTYMwasassessedwithCronbach’sα.
Sensitivity and specificity of TYM in mild Alzheimer’s
disease
We used data from the 94 patients with Alzheimer’s
disease to plot a receiver operating characteristic
curve. We randomly selected three age matched con-
trols (n=282) from the 540 controls for each patient
with mild Alzheimer’s disease. We calculated positive
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Fig 1 | Mean total TYM scores (out of maximum possible score
of 50) in control participants grouped according to age
(decade). Errors bars are 2SE. Post-hoc testing showed
significant impairment in performance for participants aged
>80 compared with all younger age groups except age 71-80
(mean difference in score between age groups 61-70 and >80
was 2.7, P=0.002)
Table 1 |Average scores on memory test (TYM),
Addenbrooke’s cognitive examination-revised (ACE-R), and
mini-mental state examination (MMSE) and variability of
these scores for patients with Alzheimer’s disease (n=94)
Mean (SD) raw score
TYM (total) 33.2 (8.2)
ACE-R 66.9 (12.0)
MMSE 22.5 (3.8)
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scoresfordifferentprevalencesofAlzheimer’sdisease.
Sensitivity of TYM v mini-mental state examination
A direct comparison between the TYM and the mini-
mental state examination in identifying the 94 patients
withAlzheimer’sdiseasewasperformedbycalculating
the percentage of patients with Alzheimer’s disease
who were detected using the cut off of ≤42 for the
TYM and ≤23 for the mini-mental state examination
(the accepted cut off for dementia
12).
Performance of TYM v other tests in other forms of
dementia and mild cognitive impairment
In the same period, 31 patients (17 men, 14 women;
average age 63.3) with other degenerative dementias
seen in the Addenbrooke’s memory clinic as new
patientsweregiventheTYMandAddenbrooke’scog-
nitive examination-revised. Of these patients, 16 had
dementia with Lewy bodies, 13 had frontotemporal
dementia, and two had progressive supranuclear
palsy.Thediagnosesweremadeaccordingtoaccepted
criteria.
13-15 Pearson coefficients were used to calculate
the correlation between the TYM scores and the other
examinations.
TYM in mild cognitive impairment
Fourteen patients in the mild cognitive impairment
cohort (average age 67.9) were given the TYM as
well as the Addenbrooke’s examination. We com-
pared these scores with the TYM scores attained by
the controls used for the Alzheimer’s cohort.
Inter-rater variability
Three individuals scored the same 100 TYM sheets
(38 patients, 62 controls) using the scoring sheet.
One was a consultant experienced in the diagnosis
of degenerative dementia (JB), one was a neurology
specialist registrar working in the memory clinic
(GP), and one a registered general nurse (LAB) with
no specialised experience of patients with dementia
who received 10 minutes of tuition. The tests were
scored independently.
RESULTS
Reliability and normative data
The TYM was filled in quickly and efficiently by con-
trols and patients with minimal supervision from a
receptionist or nurse. The average time for a control
to complete the test was five minutes.
The value of Cronbach’s α for all participants and
subsets was 0.80. Figure 1 shows the results for control
participants grouped by age. The average TYM score
wasabout47forages18-70.Abovetheageof70,there
wasasmalldeclineinperformance,whichbecamesig-
nificant above the age of 80. One way analysis of var-
iance confirmed a significant effect of age group on
total TYM score (F5,534=6.4, P<0.001) and showed a
significant effect of age on the subscores: for copy
(F5,534=5.4, P<0.001), semantic knowledge
(F5,534=3.7, P=0.003), calculation (F5,534=3.1,
P=0.008), fluency (F5,534=5.2, P<0.001), similarities
(F5,534=3.7, P=0.002), anterograde memory
(F5,534=3.5, P<0.004), and help required (F5,534=8.0,
P<0.001). All subscores except semantic knowledge
showed a mild decrease with increasing age; semantic
knowledge showed a small improvement.
Wecomparedtheperformanceof100controlsfrom
relatives in the memory clinic at Addenbrooke’s with
the performanceof100 agematchedcontrolsfromthe
other hospitals. The mean age for both groups was
65 years (t200=0.04, P=0.97). Mean TYM scores were
similarinthetwogroups(46.8v47.4,t200=1.3,P=0.19).
WeexaminedtheeffectofsexonTYMscoresbycom-
paringtheaveragescoresfor100menand100womenin
a cohort of age matched controls. Mean age for both
groups was 61 years (t200=0.1, P=0.92). The mean score
for both groups was 47.4 (t200=0.05, P=0.96).
Alzheimer’s disease and test validation
Ninety four patients with Alzheimer’s with an average
age of 69.0 (SD 8.5) were tested with the TYM, the
Addenbrooke’s cognitive examination-revised, and
the mini-mental state examination. Table 1 shows
the average scores.
Table 2 |Comparison of performance (mean (SD) scores) on TYM (total and subscores)
between patients with Alzheimer’sd i s e a s e( n =94) and age matched controls (n=282)
Subscore (maximum) Controls Patients Difference P value*
Orientation (10) 9.9 (0.5) 8.3 (2.0) 1.6 <0.001
Copying (2) 1.8 (0.6) 1.7 (0.7) 0.1 0.09
Semantic knowledge
(3)
2.6 (0.6) 1.4 (1.0) 1.3 <0.001
Calculation (4) 3.7 (0.6) 3.1 (1.2) 0.7 <0.001
Fluency (4) 3.5 (1.0) 2.2 (1.5) 1.4 <0.001
Similarities (4) 3.4 (1.0) 3.0 (1.3) 0.5 0.002
Naming (5) 4.9 (0.4) 4.4 (1.1) 0.5 <0.001
Visuospatial 1 (3) 2.7 (0.7) 1.8 (1.2) 1.0 <0.001
Visuospatial 2 (4) 3.7 (0.7) 2.9 (1.5) 0.8 <0.001
Anterograde (6) 5.2 (1.5) 0.9 (1.8) 4.2 <0.001
Executive (help) (5) 5.0 (0.2) 3.7 (1.2) 1.3 <0.001
Total (50) 46.6 (4.0) 33.2 (8.2) 13.4 <0.001
*Two tailed significance (uncorrected). Significance values shown are for independent samples t tests and are
uncorrected; after Bonferroni correction for multiple comparisons level for significance is P=0.004.
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Fig 2 | Receiver operating characteristic curve for TYM scores
differentiating between healthy controls (n=282) and patients
with Alzheimer’s disease (n=94)
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between all scores in patients with Alzheimer’s
(TYM v Addenbrooke’sR
2=0.66, P<0.001; TYM v
mini-mental R
2=0.51, P=0.001; Addenbrooke’s v
mini-mental R
2=0.70, P<0.001). The Addenbrooke’s
examination contains the mini-mental state examina-
tion;theTYMhasmuchlessincommonwiththemini-
mental or Addenbrooke’s examinations.
Older patients with Alzheimer’s (aged over 70)
scored slightly better on the TYM than the younger
patients with Alzheimer’s, though the differences did
not approach significance (average score 33.8 v 32.8,
t78=0.57, P=0.57).
Comparison of TYM scores
Table 2 shows comparisons between the total TYM
score and subscores for patients and controls. The
mean age was the same in both groups (69.0). As
expected, patients with Alzheimer’s were particularly
impaired on anterograde memory scores relative to
controls. Patients also scored poorly on semantic
knowledge, fluency, visuospatial tasks, and executive
function. After Bonferroni correction for multiple
comparisons all subtests except sentence copying
showed a significant decrease in patients with Alzhei-
mer’s compared with controls.
Sensitivity and specificity of TYM
The area under the ROC curve for differentiating
between mild AD and controls was 0.95 (fig 2). If a
single cut off is required then a TYM score of ≤42 pre-
dicts mild Alzheimer’s in this population, with a sensi-
tivity of 93% and specificity of 86%. Reducing the cut
offto≤39increasesthespecificityto95%,whileraising
the cut off to ≤44 increases the sensitivity to 96%.
Table 3 shows the negative and positive predictive
value for various TYM scores at different prevalences
of Alzheimer’s. Negative predictive values are high:
100% for a score of ≤42 with a prevalence of Alzhei-
mer’s up to 5%. Positive predictive values are lower: a
score of ≤42 has a predictive value of 26% with a pre-
valence of Alzheimer’s of 5%.
Comparison of sensitivity
We compared the power of the TYM and the mini-
mental state examination to detect the 94 patients
with Alzheimer’s. With a cut off of ≤42 the TYM
detected 93%. With the established cut off of ≤23 the
mini-mental state examination detected 52%.
12
TYM in non-Alzheimer’s dementias
Forthe31patientswithnon-Alzheimer’sdementiathe
mean TYM score was 38.9/50 (SD 8.6), the mean
Addenbrooke’s score was 77/100 (SD 16.0), and the
mean mini-mental score was 25.3/30 (SD 4.1). The
average mini-mental score is above the cut off for
dementia,whiletheTYMandAddenbrooke’saverage
scores are well below it, suggestingsuperior sensitivity
of the TYM and the Addenbrooke’s testin the diagno-
sis of non-Alzheimer’s dementias.
The numbers with these individual diseases are too
small to be meaningful, but there is a good correlation
between the TYM scores of these 31 patients and the
other scores (TYM v Addenbrooke’s, Pearson’s
R
2=0.77; TYM v mini-mental, Pearson’sR
2=0.74;
both P<0.001).
TYM in patients with mild cognitive impairment
The patients with mild cognitive impairment scored
highly on all cognitive tests, averaging 27.8/30 on the
mini-mental state examination, 86.9 on the Adden-
brooke’s examination, and 45/50 on the TYM. Their
scores on 10 of the subtests of TYM were similar to con-
trols, but they tended to score worse than controls on
anterograde memory (3.4/6 v 5.2/6, t13.5=2.7, P=0.02
uncorrected).
Inter-rater variability
The TYM scores calculated by the three raters were
highly correlated (table 4).
DISCUSSION
In this cross sectional study, the new “test your mem-
ory” test (TYM) was quick to use and detected 93% of
cases of Alzheimer’s disease. Control participants
completed the TYM quickly and accurately. From
Table 3 |Results of receiver operating characteristic analysis for detection of Alzheimer’s disease with TYM in 94 patients with Alzheimer’sa n d2 8 2a g e
matched controls
Score False +ve rate Specificity (%) False −ve rate Sensitivity (%)
Prevalence
1% 5% 10% 20% 30%
PPV NPV PPV NPV PPV NPV PPV NPV PPV NPV
≤38 4 96 25 75 16 100 50 99 68 97 82 94 89 90
≤39 5 95 19 81 14 100 46 99 64 98 80 95 87 92
≤4 0 8 9 2 1 7 8 3 91 0 0 3 59 9 5 49 8 7 29 6 8 2 9 3
≤4 1 9 9 1 1 3 8 7 91 0 0 3 49 9 5 29 8 7 19 7 8 1 9 4
≤42 14 86 7 93 6 100 26 100 42 99 62 98 74 97
≤43 17 83 6 94 5 100 23 100 38 99 58 98 70 97
≤44 19 81 5 96 5 100 21 100 36 99 56 99 68 98
≤45 25 75 3 97 4 100 17 100 30 100 49 99 62 98
PPV=positive predictive value; NPV=negative predictive value.
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50, with a small decline after this age. Scores on all
subsets of the TYM deteriorated with age, with the
exception of semantic knowledge (these questions
were designed for older patients).
Many of the controls were relatives of patients
attending the memory clinic and came from the same
population base. There was a slight male bias in the
patients and slight female bias in the controls, but
there was no significant difference in TYM scores
between male and female controls. We recruited
more controls from two other hospitals in East Anglia
because the age range and number of the memory
cliniccontrolswaslimited.ThecontrolsfromtheCam-
bridge memory clinic might have been expected to
score slightly higher, but actually scored slightly
lower.Thiseffectwasnotlargeenoughtobesignificant
or to affect the results. Control participants were
screenedforahistoryofmemoryproblemsandneuro-
logical disease but not for other problems such as
depression or vascular disease; such influences would
be expected to reduce the TYM scores of controls and
reduce differences in cognitive function between
patients and control participants.
The TYM score of controls remained remarkably
constant in widely different age ranges in both sexes
and all geographical backgrounds. This is likely to be
a ceiling effect. The TYM test was designed to be easy
for normal controls to allow quick and accurate com-
pletion. Most controls of all ages scored almost full
marks(forexample,68%ofcontrolsaged60-69scored
48-50). This ceiling effect suggests that education and
social class would have only mild effects on the TYM
score, but we did not formally assess this. The reason
for the low scoring controls was often apparent from
thescoresheet—lackofinterest,readingproblems,ora
senseofhumour.Somelowscoringcontrolsagedover
70 show a typical pattern for mild Alzheimer’s and
might be in the early stages (they were still included
in the control group).
Use in patients with Alzheimer’s disease
Patients with Alzheimer’s disease performed much
poorer than controls on the TYM. They scored an
average of 33/50; 13.4 points below the control
group. Subtest analysis of scores in patients with Alz-
heimer’s showed that all parts of the test, except copy-
ingasentence,areperformedlesswellbypatientsthan
controls. There is the expected pattern in patients with
Alzheimer’sperformingpoorlyontestsofanterograde
memory, semantic knowledge, fluency, and
visuospatial tasks. They perform better (although still
significantly worse than controls) on naming, orienta-
tion,similarities,andcalculationsubtests.Patientsper-
formed worse than controls in the copying subtest,but
the difference was not significant; this test was prob-
ably too easy to identity patients with mild Alzhei-
mer’s.
We separately analysed patients with mild memory
problems. These patients had a clinical diagnosis of
amnestic mild cognitive impairment and scored well
on the Addenbrooke’s examination (>83). Amnestic
mild cognitive impairment can be a prodrome of Alz-
heimer’s, but some affected patients have mild pro-
blems that do not progress.
11 The Addenbrooke’s test
is a good indicator of which patients with amnestic
mild cognitive impairment (or questionable dementia)
will develop progressive dementia in the two years
after testing: patients who score ≤80 are likely to pro-
gress, patients who score >80 are unlikely to
progress.
10 In this study as we used the higher cut off
of≤83,theacceptedcutofffordementiafortheAdden-
brooke’s test,
5 some non-progressive patients might
have been included in the Alzheimer’s cohort. The
patients with mild cognitive impairment scored an
average of 45/50 on the TYM, with a trend towards
problems in anterograde memory; they scored well
in other subtests of the test.
Patients seen in the memory clinic in Cambridge
could be different from those seen in other clinics.
Cambridge attracts some younger patients with Alz-
heimer’s from a wide area. The memory clinic serves
a dual purpose in Cambridge, and many of the older
patients in the study were local and referred directly
from primary care. We separately examined the per-
formance of the 42 patients with Alzheimer’s aged 70
orover(averageage76.8).Therewaslittledifferencein
these patients compared with the younger patients
eitherinoverallTYMscore(33.9v32.6)orinthesubt-
est pattern. This suggests that it is a useful test to detect
older patients with Alzheimer’s.
ThesensitivityandspecificityoftheTYMfordetect-
ing Alzheimer’s in this cohort is high. A score of ≤42
detects 93% of cases of mild Alzheimer’s with a speci-
ficityof86%;ascoreof≤44detects96%ofpatientswith
mild Alzheimer’s. The prevalence of dementia and
mild cognitive problems (often with reduced insight)
in the population sets a limit on the specificity of a test.
Thetestersandraterswereusuallyawareofwhether
individualswerepatientsorcontrolsatthetimeoftest-
ing or rating. As individuals fill in the test sheet them-
selves, the tester has minimal influence on the score.
All scores were checked by a single rater (JB) using
the scoring sheet. The use of a strict scoring scheme
minimises the influence of the rater. Scores calculated
by the single rater correlated closely with the scores of
the other two raters in the inter-rater analysis.
TYM v mini-mental state examination
The mini-mental state examination has been the stan-
dard short cognitive test for 30 years. It has proved
valuable in the assessment of patients with established
Table 4 |Inter-rater agreement for memory test with three different raters, rating 100
randomly chosen participants (38 patients and 62 controls)
Rater
Mean(SD)rawscore
(/50)
Pearson’s r (r2) correlation
Consultant Trainee Nurse
Consultant 43.8 (6.4) — 0.99 (0.98) 0.99 (0.98)
Trainee 43.8 (6.5) 0.99 (0.98) — 0.99 (0.98)
Nurse 43.8 (6.5) 0.99 (0.98) 0.99 (0.98) —
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requirements for a brief screening test for the non-spe-
cialist: minimal operator time, testing a wide range of
cognitive domains, and sensitivity to mild Alzhei-
mer’s.
Themini-mentalstateexaminationtakesanaverage
of eight minutes to administer. Many clinicians find
time to complete this but with an average consultation
time in general practice in Europe of 10.7 minutes
16
this is too long. Around 58% of physicians in hospital
practice thought the length of time taken to administer
the mini-mental examination was too long.
17
The mini-mental state examination tests several dif-
ferent cognitive domains but has a bias towards domi-
nant parietal and temporal lobe function. It is a useful
test of orientation, but the language and memory tests
are too easy
1819 and there is only a single point for
visuospatial tasks. These drawbacks lead to the major
problem with the test—that it is insensitive in the diag-
nosisofmildAlzheimer’s.
518-20Incommunityandhos-
pital studies the sensitivity of the mini-mental state
examination in detecting Alzheimer’s using the estab-
lished cut off of ≤23 is low, varying from 49% to
69%.
519-21 In our study it detected 52% of patients
with Alzheimer’s. This low detection rate probably
reflects the high number of patients with mild Alzhei-
mer’s.
The TYM fulfils the three requirements. If a patient
completes the test while in the waiting area supervised
bythereceptionist,itcanbescoredandanalysedbythe
doctor in two minutes. If there is time during the con-
sultation to observe the patients filling in the test, this
can also be a useful aid to diagnosis.
The11TYMtasksexaminemorecognitivedomains
than the mini-mental state examination, with less bias
towards dominant hemisphere language functions.
The language and memory tests are more difficult.
The inclusion of two visuospatial tasks, contributing
7/50points,isimportantindistinguishingAlzheimer’s
disease from pure amnestic syndromes. The test has a
highsensitivityfordetectingAlzheimer’s.Inourstudy
itdetected93%ofcasesofAlzheimer’scomparedwith
52% detected by the mini-mental state examination.
There are some additional problems with the mini-
mental state examination. The score is influenced by
how the tester asks the questions and also location—
spatially disorientated patients might score 4 more
points at home than in the clinic on the question of
current location. The TYM is less influenced by the
tester as it is filled in by the patient and will not vary
with location.
The small range of scores in the mini-mental state
examination limit its suitability for monitoring, but it
is widely used for this purpose. It is the main test cho-
sen by the National Institute for Health and Clinical
Excellence (NICE) for deciding which patients in the
UnitedKingdomshouldhavecholinesteraseinhibitors
and for monitoring their response to treatment.
22 The
TYM has a much wider scoring range than the mini-
mentalstateexamination,withover13pointsbetween
the average control and the average patient with mild
Alzheimer’s. In the group of 94 patients with Alzhei-
mer’sinthisstudytherangeofmini-mentalscoreswas
14-30 while the range of TYM scores was 9-50 (2.5
times greater).
TYM v Addenbrooke’s cognitive examination
TheoriginalandrevisedAddenbrooke’sexaminations
are sensitive and specific in the diagnosis of degenera-
tive dementia.
45 The major drawback of the revised
examinationisthatitfailstofulfilthetimerequirement
for a test for non-specialists, taking 20 minutes to
administer and score. It tests a similar number of cog-
nitive domains to the TYM and is sensitive to mild
Alzheimer’s.
Therewasastrongcorrelationbetweenthememory
score and the Addenbrooke’s score in both Alzhei-
mer’s and non-Alzheimer’s dementias. The TYM
score averages 50% of Addenbrooke’s score, enabling
thetwoteststobeeasilycompared.Bothtestsprovidea
permanent record of the patient’s performance, which
can be assessed later.
TYM v abbreviated mental test and other brief tests
Several brief cognitive tests have been published for
screening for memory problems.
2324 Many of these
are simple—such as clock drawing tests. These can be
useful in distinguishing patients with established Alz-
heimer’s from normal controls but are too limited for
routine screening for mild Alzheimer’s.
25
The abbreviated mental test
2627 is the established
brief test. It fulfils the time requirement, taking only
two minutes to administer. It does not test many cog-
nitive domains and hasa strongbias (40% of the score)
towards orientation, which is useful to detect
delirium.
28 It is less sensitive and specific than the
mini-mental state examination in detecting mild
Alzheimer’s.
29 There are additional problems with
the abbreviated mental test, which is not given and
scored consistently by regular users.
30
Other strengths and weaknesses of TYM
The TYM has several other advantages over current
bedside cognitive tests. There is a brief but rigorous
scoring system. Inter-rater agreement for scoring is
excellent. Ten minutes’ training and the scoring sheet
allowedanurse,withoutexperienceofmemoryclinics,
to score the TYM sheets as accurately as a specialist.
WHAT IS ALREADY KNOWN
There is no available short cognitive test that is quick to use, examines various skills, and is
sensitive to Alzheimer’sd i s e a s e
There is confusion over how to score and interpret current short cognitive tests
WHAT THIS PAPER ADDS
The new “test your memory” (TYM) test is quick to use, examines 10 cognitive skills, and
detects 93% of cases of Alzheimer’s disease
There are normative data and a scoring sheet to allow consistent scoring and interpretation
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confusion that arises with scoring and interpreting the
mini-mental state examination and the abbreviated
mental test.
Cognitive testing usually depends on the tester and
patient speaking the same language. The simplicity of
theTYMshouldallowittobeadministeredandscored
in a different language with help from a relative. It is
currently being translated into four different lan-
guages. A minor adjustment to the semantic knowl-
edge question (president for prime minister) is
needed for American, Irish, and Australian use. Ver-
sions are being developed for UK patients who do not
speak English as their first language; in these versions
there are variations in the semantic knowledge and
drawings to suit the background of the individual.
Normal values,sensitivity, and specificity are on the
scoring sheet. As the test is filled in by the patient with
little help and marked with the help of a scoring sheet,
the tester and rater have little influence on the score.
The high negative predictive value of scores ≥42
shows that in unselected groups a good score makes
Alzheimer’s disease unlikely and the TYM is a good
screeningtestformemoryproblems.Ascoreabove42
(thatis,≥43)correctlyexcludesthediagnosisofAlzhei-
mer’s diseaseon97% of occasions,even when the pre-
valence is as high as 30%. In unselected groups the
positive predictive value of a score of ≥42 is relatively
low,showingthatthetestalonecannotbeusedtodiag-
noseAlzheimer’sdisease.Inselectedgroupswherethe
prevalence of Alzheimer’s will be higher—for exam-
ple,olderpatientswithmemorycomplaints—theposi-
tive predictive value of a score ≥42 is much higher.
The TYM was used successfully in patients outside
thisstudywithmoreseveredementia,visualproblems,
or other physical disability. The tester needs to fill in
the form with these patients and some tasks might be
toodifficult,sothescoresofthesepatientsarenotcom-
parable with scores of the patients or controls in this
study. The test is also useful for patients with hearing
impairment who have difficulty with verbal cognitive
tests.
The TYM seems more sensitive than the mini-men-
tal state examination in screeningfor non-Alzheimer’s
dementias. In the small group of such patients in our
study the average mini-mental score was 25, close to
the average for the population. The TYM score in the
same group was 39, eight points below the average
control score.
Adisadvantageofthememorytestistheneedforthe
specially printed sheets, though the Addenbrooke’s
cognitive examination-revised has a similar require-
ment. A website is being developed to help to solve
this problem.
This work would not have been possible without the nurses and
receptionists at Queen Elizabeth Hospital, King’sL y n n ,N o r t h
Cambridgeshire Hospital, Wisbech, and Addenbrooke’sH o s p i t a l ,
Cambridge, who administered the tests. We thank colleagues in the
memoryclinic,Cambridge,forpermissiontoincludetheirpatientsandfor
helpfuldiscussions.Awebsiteisbeingprepared(www.tymtest.com)that
will allow downloading of tests, scoring sheets, and instructions.
Contributors: JB devised and helped to design the TYM, he helped to
perform and coordinated the clinical research, and wrote the first draft of
the paper. GP helped in the clinical testing and in the writing of the paper
and was an inter-rater tester. KD performed much of the clinical testing
and scoring. PC performed the statistical analysis and prepared the
figures and tables. LAB helped design the test and was an inter-rater
tester. JB is guarantor.
Funding: GP was supported by Alzheimer’s Research Trust (UK) and the
Cambridge Commonwealth Trust. PC was supported by the Stroke
Association.Theauthorsareindependentofanyfundersforthiswork.All
authors had access to all data in this study.
Competing interests: None declared.
Ethical approval: This study was performed under ethical approval from
Cambridgeshire 2 research ethics committee. All participants gave
informed consent.
1 Ferri C, Prince M, Brayne C, Brodaty H, Fratiglioni L, Ganguli M, et al.
Global prevalence of dementia: a Delphi consensus study. Lancet
2006;366:2112-7.
2 Graham JE, Rockwood K, Beattie BL, Eastwood R, Gauthier S,
TuokkoH,etal.Prevalenceandseverityofcognitiveimpairmentwith
and without dementia in an elderly population. Lancet
1997;349:1793-6.
3 Folstein MF, Folstein SE, McHugh PR. “Mini-mental state.” Ap r a c t i c a l
method for grading the cognitive state of patients for the clinician. J
Psychiatr Res 1975;12:189-98.
4 M i o s h iE ,D a w s o nK ,M i t c h e l lJ ,A r n o l dR ,H o d g e sJ .T h e
Addenbrooke’s cognitive examination revised (ACE-R). A brief
cognitive test battery for dementia screening. Int J Geriatr Psychiatry
2006;21:1078-85.
5 Mathuranath PS, Nestor PJ, Berrios GE, Rakowicz W, Hodges JR. A
brief cognitive test battery to differentiate AD and frontotemporal
dementia. Neurology 2000;55:1613-20.
6 Mckhann G, Drachman D, Folstein M, Katzman R, Price D,
Stadlan EM. Clinical diagnosis of AD. Neurology 1984;34:939-44.
7 Portet F, Ousset PJ, Visser PJ, Frisoni GB, Nobili F, Scheltens Ph, et al.
Mild cognitive impairment (MCI) in medical practice: a critical review
of the concept and new diagnostic procedure. Report of the MCI
WorkingGroupoftheEuropeanConsortiumonAlzheimer’sDisease.J
Neurol Neurosurg Psychiatr 2006;77:714-8.
8 MorrisJC,StorandtM,MillerP,McKeelD,PriceJ,RubinE,BergL.Mild
cognitiveimpairmentrepresentsearly-stageAlzheimerdisease.Arch
Neurol 2001;58:397-405.
9 M a r k e s b e r yW ,S c h m i t tF ,K r y s c i oR ,D a v i sD ,S m i t hC ,W e k s t e i nD .
Neuropathological substrate of mild cognitive impairment. Arch
Neurol 2006;63:38-46.
10 Galton C, Erzinclioglu S, Sahakian BJ, Antoun N, Hodges JR. A
comparison of the Addenbrooke’s cognitive examination (ACE),
conventional neuropsychological assessment, and simple MRI-
based medial temporal lobe evaluation in the early diagnosis of
Alzheimer’sd i s e a s e .Cog Behav Neurol 2005;18:144-50.
11 Ganguli M, Dodge HH, Shen C, DeKosky ST. Mild cognitive
impairment, amnestic type. An epidemiological study. Neurology
2004;63:115-21.
12 Feher EP, Mahurin RK, Doody RS, Cooke N, Sims J, Pirozzolo FJ.
Establishing the limits of the mini-mental state examination of
subsets. Arch Neurol 1992;49:87-92
13 McKeithIG,GalaskoD,KosakaK,PerryEK,DicksonD,HansenL,etal.
Consensus guidelines for the clinical and pathological diagnosis of
dementia with Lewy bodies (DLB). Report of the consortium on DLB
international workshop. Neurology 1996;47:1113-24.
14 NearyD,SnowdenJS,GustafsonL,Passant U,StussD,BlackS,et al.
Frontotemporal lobar degeneration: a consensus on clinical
diagnostic criteria. Neurology 1998;51:1546-54.
15 Litvan I, Agid Y, Calne D, Campbell G, Dubois B, Duvoisin RC, et al.
Clinical research criteria for the diagnosis of progressive
supranuclear palsy (Steele-Richardson-Olszewski syndrome): report
of the NINDS-SPSP international workshop. Neurology 1996;47:1-9.
16 Deveugele M, Derese A, van den Brink-Muinene A, Bensing J, De
Maeseneer J. Consultation length in general practice: cross sectional
study in six European countries. BMJ 2002;325:472.
17 Tangalos E, Smith G, Ivnik R, Petersen R, Kokmen E, Kurland L, et al.
The mini-mental state examination in general medical practice:
clinical utility and acceptance. Mayo Clin Proc 1996;71:829-37.
18 Naugle RI, Kawczak K. Limitations of the mini-mental state
examination. Cleve Clin J Med 1989;56:277-81.
19 Galasko D, Klauber M, Hofstetter C, Salmon D, Lasker B, Thal L. The
mini-mental state examination in the early diagnosis of AD. Arch
Neurol 1990;47:49-52.
20 Tombaugh TN, McIntyre NJ. The mini-mental state examination: a
comprehensive review. JA mG e r i a t rS o c1992;40:922-35.
21 Bier J-C, Donckels V, Van Eyll E, Claes T, Slama H, Fery P, et al. The
FrenchAddenbrooke’s cognitive examinationiseffective indetecting
RESEARCH
BMJ | ONLINE FIRST | bmj.com page 7 of 8dementia in a French-speaking population. Dement Geriatr Cogn
Disord 2005;19:15-7.
22 NICE technology guidelines 111. London: National Institute for
Health and Clinical Excellence, 2007.
23 Lorentz WJ, Scanlan JM, Borson S. Briefscreening tests for dementia.
Can J Psychiatry 2002;47:723-32.
24 Woodford H, George J. Cognitive assessment in the elderly: a review
of clinical methods. QJM 2007;100:469-84.
25 Philpot M. The clock-drawing test: a critique. Int Psychogeriatr
2004;16:251-6.
26 Hodkinson HM. Evaluation of a mental test score for assessment of
mental impairment in the elderly. Age Ageing 1972;1:233-8.
27 Jitapunkul S, Pillay I, Ebrahim S. The abbreviated mental test: its use
and validity. Age Ageing 1991;20:332-6.
28 Ni Chonchubhair A, Valacio R, Kelly J, O’Keefe S. Use of the
abbreviated mental test to detect postoperative delirium in elderly
people. Br J Anaesthesia 1995;75:481-2.
29 Mackenzie DM, Copp P, Shaw RJ, Goodwin GM. Brief cognitive
screening of the elderly: a comparison of the mini-mental state
examination (MMSE), abbreviated mental test (AMT) and mental
status questionnaire (MSQ). Psychol Med 1996;26:427-30.
30 Holmes J, Gilbody S. Differences in use of abbreviated mental test
score by geriatricians and psychiatrists. BMJ 1996;313:465.
Accepted: 6 February 2009
RESEARCH
page 8 of 8 BMJ | ONLINE FIRST | bmj.com